Novel application of medicinal composition

A technology of composition and medicine, applied in the field of medicine

Active Publication Date: 2014-01-22
BEIJING CHENGYI INVESTMENT CO LTD
View PDF1 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0020] In the prior art, the pharmaceutical composition with epimedium, Ligustrum lucidum, Polygonatum odoratum, black soybean, Sophora japonica, mulberry, raspberry, American ginseng, donkey-hide gelatin and Paecilomyces spp. Fu...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel application of medicinal composition
  • Novel application of medicinal composition

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0035] The composition of the pharmaceutical composition: 25 parts by weight of Epimedium, 15 parts by weight of Ligustrum lucidum, 10 parts by weight of Polygonatum odoratum, 10 parts by weight of black soybean, 10 parts by weight of Sophora japonica, 10 parts by weight of mulberry, 10 parts by weight of raspberry, American ginseng 2.5 parts by weight, 5 parts by weight of donkey-hide gelatin, and 2.5 parts by weight of Paecilomyces hematodes mycelium powder.

Embodiment 2

[0037] The composition of the pharmaceutical composition: 16 parts by weight of Epimedium, 12 parts by weight of Ligustrum lucidum, 8 parts by weight of Polygonatum odoratum, 8 parts by weight of black soybean, 8 parts by weight of Sophora japonica, 8 parts by weight of mulberry, 8 parts by weight of raspberry, American ginseng 2 parts by weight, 3 parts by weight of donkey-hide gelatin, and 2 parts by weight of Paecilomyces hematodes mycelium powder.

Embodiment 3

[0039] The composition of the pharmaceutical composition: 32 parts by weight of Epimedium, 18 parts by weight of Ligustrum lucidum, 12 parts by weight of Polygonatum odoratum, 12 parts by weight of black soybean, 12 parts by weight of Sophora japonica, 12 parts by weight of mulberry, 12 parts by weight of raspberry, American ginseng 4 parts by weight, 8 parts by weight of donkey-hide gelatin, and 4 parts by weight of Paecilomyces hematodes mycelium powder.

[0040] The pharmaceutical composition of the above examples, when used in the following examples, should be decocted in water after the traditional Chinese medicine composition is mixed.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses novel application of a medicinal composition adopting epimedium, glossy privet fruit, radix polygonati officinalis, black soybean, sophora flower, mulberry, raspberry, American ginseng, donkey-hide gelatin, paecilomyces hepialid filament powder as main raw materials in preparing medicaments for treating diminished ovarian reserve and/or promoting endometrial development. The medicinal composition can be used for improving the ovarian reserve function, and promoting endometrial development by improving gynecologic endocrine function and increasing endometrium thickness, and has a wide application prospect.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to the application of a pharmaceutical composition in the preparation of medicines for treating ovarian reserve function decline and / or promoting endometrium development. Background technique [0002] Decreased ovarian reserve is a transitional stage of premature ovarian failure, which refers to the weakened ability of the ovaries to produce eggs and the decline in follicle quality, leading to decreased female fertility and lack of sex hormones, also known as "ovarian aging". The clinical manifestations are less menstruation, thin menstruation, even amenorrhea, infertility, accompanied by different degrees of perimenopausal symptoms, such as hot flashes, hyperhidrosis, facial flushing, emotional instability, low libido, vaginal dryness, osteoporosis Wait. If it cannot be corrected in time, it may develop into premature ovarian failure. It is a gradual process from the decline of o...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/8969A61P15/08A61K35/36
Inventor 程雪翔
Owner BEIJING CHENGYI INVESTMENT CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap